These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18607140)

  • 1. The kidney and hypertension: causes and treatment.
    Sica DA
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):541-8. PubMed ID: 18607140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic basis and treatment considerations in chronic kidney disease-related hypertension.
    Sica D; Carl D
    Semin Nephrol; 2005 Jul; 25(4):246-51. PubMed ID: 16202697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
    Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
    BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment problems of nephrogenic arterial hypertension].
    Abrarova ER; Kosorukova NN
    Ter Arkh; 1996; 68(6):77-82. PubMed ID: 8771695
    [No Abstract]   [Full Text] [Related]  

  • 6. The kidney, hypertension, and remaining challenges.
    Khosla N; Kalaitzidis R; Bakris GL
    Med Clin North Am; 2009 May; 93(3):697-715, Table of Contents. PubMed ID: 19427500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephroangiosclerosis or hypertensive nephropathy].
    del Río Vázquez A
    Rev Clin Esp; 1994 Aug; 194(8):620-2. PubMed ID: 7938843
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1995 update of the working group reports on chronic renal failure and renovascular hypertension. National High Blood Pressure Education Program Working Group.
    Arch Intern Med; 1996 Sep; 156(17):1938-47. PubMed ID: 8823147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherosclerotic renovascular hypertension: clinical findings and results of treatment over 15 years].
    Alfonzo JP; Rosario MN; Ugarte C; Banasco J; Fraxedas R; Lahera J
    Nefrologia; 2003; 23(2):150-9. PubMed ID: 12778880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in patients with renal artery stenosis treated with stent placement with embolic protection compared with those treated with stent alone.
    Khosla A; Misra S; Greene EL; Pflueger A; Textor SC; Bjarnason H; McKusick MA
    Vasc Endovascular Surg; 2012 Aug; 46(6):447-54. PubMed ID: 22692467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renovascular hypertension: an update.
    Elliott WJ
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):522-33. PubMed ID: 18607138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
    Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
    Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and dialysis.
    Hörl MP; Hörl WH
    Kidney Blood Press Res; 2003; 26(2):76-81. PubMed ID: 12771530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The double challenge of resistant hypertension and chronic kidney disease.
    Rossignol P; Massy ZA; Azizi M; Bakris G; Ritz E; Covic A; Goldsmith D; Heine GH; Jager KJ; Kanbay M; Mallamaci F; Ortiz A; Vanholder R; Wiecek A; Zoccali C; London GM; Stengel B; Fouque D; ; ;
    Lancet; 2015 Oct; 386(10003):1588-98. PubMed ID: 26530623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension of renal origin.
    Acchiardo S
    Medicina (B Aires); 1979; 39 Suppl 1():66-70. PubMed ID: 550046
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretic herb Gomphrena celosioides Mart. (Amaranthaceae) promotes sustained arterial pressure reduction and protection from cardiac remodeling on rats with renovascular hypertension.
    de Paula Vasconcelos PC; Tirloni CAS; Palozi RAC; Leitão MM; Carneiro MTS; Schaedler MI; Silva AO; Souza RIC; Salvador MJ; Junior AG; Kassuya CAL
    J Ethnopharmacol; 2018 Oct; 224():126-133. PubMed ID: 29842964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.
    Corriere MA; Pearce JD; Edwards MS; Stafford JM; Hansen KJ
    J Vasc Surg; 2008 Sep; 48(3):580-7; discussion 587-8. PubMed ID: 18727962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.